The importance of regorafenib and lenvatinib in the treatment of hepatocellular carcinoma

被引：0
|
作者：
Cihan, Yasemin Benderli [1 ]
机构：
[1] Kayseri Educ & Res Hosp, Dept Radiat Oncol, Kayseri, Turkey
来源：
JOURNAL OF BUON | 2019年 / 24卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：867 / 867
页数：1
相关论文
共 50 条
  • [1] A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
    Kudo, M.
    [J]. LIVER CANCER, 2017, 6 (03) : 177 - 184
  • [2] Regorafenib for treatment of hepatocellular carcinoma
    Sherman, Morris
    [J]. HEPATOLOGY, 2018, 67 (03) : 1162 - 1165
  • [3] Regorafenib for the treatment of hepatocellular carcinoma
    Tovoli, F.
    Granito, A.
    De Lorenzo, S.
    Bolondi, L.
    [J]. DRUGS OF TODAY, 2018, 54 (01) : 5 - 13
  • [4] Safety and efficacy of sorafenib followed by regorafenib or lenvatinib in patients with hepatocellular carcinoma
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Takeda, Yasuhito
    Kido, Hidenori
    Iida, Noriho
    Kitahara, Masaaki
    Shimakami, Tetsuro
    Takatori, Hajime
    Arai, Kuniaki
    Kawaguchi, Kazunori
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    [J]. HEPATOLOGY RESEARCH, 2021, 51 (02) : 190 - 200
  • [5] Regorafenib: a promising treatment for hepatocellular carcinoma
    Cerrito, Lucia
    Ponziani, Francesca R.
    Garcovich, Matteo
    Tortora, Annalisa
    Annicchiarico, Brigida E.
    Pompili, Maurizio
    Siciliano, Massimo
    Gasbarrini, Antonio
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (17) : 1941 - 1948
  • [6] Experience with regorafenib in the treatment of hepatocellular carcinoma
    Granito, Alessandro
    Forgione, Antonella
    Marinelli, Sara
    Renzulli, Matteo
    Ielasi, Luca
    Sansone, Vito
    Benevento, Francesca
    Piscaglia, Fabio
    Tovoli, Francesco
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [7] Regorafenib for the treatment of unresectable hepatocellular carcinoma
    Rimassa, Lorenza
    Pressiani, Tiziana
    Personeni, Nicola
    Santoro, Armando
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (07) : 567 - 576
  • [8] Therapeutic efficacy of lenvatinib as third-line treatment after regorafenib for unresectable hepatocellular carcinoma progression
    Hiraoka, Atsushi
    Kumada, Takashi
    Hatanaka, Takeshi
    Tada, Toshifumi
    Kariyama, Kazuya
    Tani, Joji
    Fukunishi, Shinya
    Atsukawa, Masanori
    Hirooka, Masashi
    Tsuji, Kunihiko
    Ishikawa, Toru
    Takaguchi, Koichi
    Itobayashi, Ei
    Tajiri, Kazuto
    Shimada, Noritomo
    Shibata, Hiroshi
    Ochi, Hironori
    Kawata, Kazuhito
    Yasuda, Satoshi
    Toyoda, Hidenori
    Chikara, Ogawa
    Tamai, Tsutomu
    Kakizaki, Satoru
    Tojima, Hiroki
    Nagashima, Tamon
    Ueno, Takashi
    Takizawa, Daichi
    Naganuma, Atsushi
    Ohama, Hideko
    Nouso, Kazuhiro
    Tsutsui, Akemi
    Nagano, Takuya
    Itokawa, Norio
    Okubo, Tomomi
    Arai, Taeang
    Imai, Michitaka
    Koizumi, Yohei
    Nakamura, Shinichiro
    Joko, Kouji
    Michitaka, Kojiro
    Hiasa, Yoichi
    Kudo, Masatoshi
    [J]. HEPATOLOGY RESEARCH, 2021, 51 (08) : 880 - 889
  • [9] THE IMPORTANCE OF BODY COMPOSITION MEASUREMENTS DURING LENVATINIB TREATMENT IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Yamaoka, Kenji
    Kawaoka, Tomokazu
    Kosaka, Masanari
    Johira, Yusuke
    Shirane, Yuki
    Miura, Ryoichi
    Yano, Shigeki
    Murakami, Serami
    Amioka, Kei
    Naruto, Kensuke
    Ando, Yuwa
    Kosaka, Yumi
    Uchikawa, Shinsuke
    Kodama, Kenichiro
    Uchida, Takuro
    Fujino, Hatsue
    Ono, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Okamoto, Wataru
    Yamauchi, Masami
    Miki, Daiki
    Imamura, Michio
    Chayama, Kazuaki
    Aikata, Hiroshi
    [J]. HEPATOLOGY, 2022, 76 : S1386 - S1387
  • [10] Regorafenib in advanced hepatocellular carcinoma (HCC): considerations for treatment
    Kim, Kyung
    Jha, Reena
    Prins, Petra A.
    Wang, Hongkun
    Chacha, Monica
    Hartley, Marion L.
    He, Aiwu Ruth
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (05) : 945 - 954
12345